Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04383938 |
| Title | Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Aprea Therapeutics |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Mayo Clinic | Phoenix | Arizona | 85054 | United States | Details | |
| Mayo Clinic | Jacksonville | Florida | 32224 | United States | Details | |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
| Dana Farber Cancer Center | Boston | Massachusetts | 02115 | United States | Details | |
| Mayo Clinic | Rochester | Minnesota | 55902 | United States | Details | |
| Washington University | Saint Louis | Missouri | 63130 | United States | Details | |
| Vanderbilt University | Nashville | Tennessee | 37235 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |